Bhavini Mishra, Sanket Koul

Stories by Bhavini Mishra, Sanket Koul

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Rediff.com   8 Oct 2025

The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.

Good news for central govt employees on healthcare front

Good news for central govt employees on healthcare front

Rediff.com   7 Oct 2025

Now a multi-dimensional rate structure has been created for CGHS cardholders in all categories based on four different parameters, with semi-private rooms forming the base for package rates.

Cough Syrup For Kids: Centre Tightens Rules

Cough Syrup For Kids: Centre Tightens Rules

Rediff.com   4 Oct 2025

Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan.

Delhi diagnostic players oppose genetic sample outflow ban

Delhi diagnostic players oppose genetic sample outflow ban

Rediff.com   29 Sep 2025

The Delhi government's directive banning sending of genetic samples outside the city for advanced prenatal tests has hit opposition, with diagnostic players in the capital citing operational difficulties in complying with the order. This comes after the Annual Report on Registration of Births and Deaths in Delhi 2024 indicated that the city's sex ratio at birth (SRB) had dropped to 920 girls per 1,000 boys in 2024, down from 922 in 2023.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com   29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Drugmakers look to fill Rs 600 cr Novo vacuum

Drugmakers look to fill Rs 600 cr Novo vacuum

Rediff.com   25 Sep 2025

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an opportunity estimated to be worth Rs 600-800 crore in the domestic market. Some self-use disposable pens are pre-filled with insulin and others can be reused with new cartridges.

SC Verdict Instills Hope For Real Estate Reforms

SC Verdict Instills Hope For Real Estate Reforms

Rediff.com   24 Sep 2025

'The directives to enhance last-mile funding, consider revival funds, and systemic reforms across the sector are expected to revive stalled projects, improve accountability, and accelerate the delivery of affordable and mid-income housing.'

CCI to NCLAT: No player close to WhatsApp in terms of revenue, assets

CCI to NCLAT: No player close to WhatsApp in terms of revenue, assets

Rediff.com   23 Sep 2025

The Competition Commission of India (CCI) on Monday told the National Company Law Appellate Tribunal (NCLAT) that no internet intermediary could come close to WhatsApp in terms of revenues as well as assets.

Bank OTS scheme not a borrower's right without upfront payment: SC

Bank OTS scheme not a borrower's right without upfront payment: SC

Rediff.com   18 Sep 2025

The Supreme Court has ruled that a bank's one-time settlement (OTS) scheme cannot be invoked as a matter of right and that borrowers must strictly comply with its mandatory conditions, including upfront payment of a specified portion of dues, to avail themselves of the benefits of the scheme.

Mankind taps OpenAI to institutionalise AI in ops

Mankind taps OpenAI to institutionalise AI in ops

Rediff.com   18 Sep 2025

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.

WhatsApp to NCLAT: CCI exceeded powers, ruled onprivacy

WhatsApp to NCLAT: CCI exceeded powers, ruled onprivacy

Rediff.com   15 Sep 2025

"All they have done in their entire report is privacy regulation," counsel appearing for WhatsApp told the appellate tribunal.

WhatsApp User Data Belongs To Us: Meta Tells NCLAT

WhatsApp User Data Belongs To Us: Meta Tells NCLAT

Rediff.com   12 Sep 2025

'By leveraging user data from WhatsApp, Meta can enhance its technology.' 'It (user data) is collected by me, it's my personal property. Shall I give it to my competitors?'

Why Hotels Are Building Branded Residences

Why Hotels Are Building Branded Residences

Rediff.com   29 Aug 2025

'While the concept was introduced globally over four decades ago, branded residences have taken off now in India.'

Senior living market to reach $8 bn by 2030

Senior living market to reach $8 bn by 2030

Rediff.com   28 Aug 2025

With the rise in elderly population and increasing interest around the segment by developers, the senior living industry is poised to reach a market size of $8 billion by 2030 from the current $1.8 to $2 billion, according to a report by Association of Senior Living in India (ASLI) and JLL.

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com   27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

'Judges Don't Descend From Mars Or The Moon'

'Judges Don't Descend From Mars Or The Moon'

Rediff.com   21 Aug 2025

'The quality of justice is directly linked to the quality of judges -- if that suffers, justice delivery suffers.'

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com   12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com   31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

Weight-Loss Drug Battle Intensifies

Weight-Loss Drug Battle Intensifies

Rediff.com   22 Jul 2025

'Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five times what it was five years ago.'

AdFalciVax Is India's Malaria Vaccine

AdFalciVax Is India's Malaria Vaccine

Rediff.com   21 Jul 2025

'AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing single-stage malaria vaccines.'